Common Genetic Variants and Nonalcoholic Fatty Liver Disease

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 9, 2013, Pages 1191-1193

  Browning, Jeffrey D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CARBOHYDRATE; DNA; FAT DROPLET; FATTY ACID; INSULIN; LIPOPROTEIN; LYSOPHOSPHOLIPASE; LYSOPHOSPHOLIPASE LIKE 1; NEUROCAN; PHOSPHOPROTEIN PHOSPHATASE 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; AFRICAN AMERICAN; CLINICAL DECISION MAKING; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; EDITORIAL; ETHNIC GROUP; EUROPEAN AMERICAN; FATTY ACID SYNTHESIS; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HAPLOTYPE; HISPANIC; HUMAN; INSULIN RESISTANCE; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID OXIDATION; LIVER METABOLISM; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; POPULATION; PREVALENCE; PROTEIN SECRETION; RACE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; FATTY LIVER; FEMALE; HUMANS; LIPASE; MALE; MEMBRANE PROTEINS; POLYMORPHISM, GENETIC; PROTEIN PHOSPHATASE 1;

EID: 84882862678     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.05.013     Document Type: Editorial

References (26)

1. Neuschwander-Tetri B., Caldwell S. Nonalcoholic steatohepatitis:summary of an AASLD single topic conference. Hepatology 2003, 37:1202-1219.
2. White D.L., Kanwal F., El-Serag H.B. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol 2012, 10:1342-1359.
3. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
4. Argo C.K., Northup P.G., Al-Osaimi A.M., et al. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 2009, 51:371-379.
5. Francque S.M., Verrijken A., Mertens I., et al. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients. Clin Gastroenterol Hepatol 2012, 10:1162-1168. quiz e87.
6. Torres D.M., Williams C.D., Harrison S.A. Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012, 10:837-858.
7. Mofrad P., Contos M.J., Haque M., et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003, 37:1286-1292.
8. Diraison F., Moulin P., Beylot M. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab 2003, 29:478-485.
9. Donnelly K.L., Smith C.I., Schwarzenberg S.J., et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005, 115:1343-1351.
10. Iozzo P., Bucci M., Roivainen A., et al. Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals. Gastroenterology 2010, 139:846-856.
11. Sunny N.E., Parks E.J., Browning J.D., et al. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab 2011, 14:804-810.
12. Fabbrini E., Mohammed B.S., Magkos F., et al. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 2008, 134:424-431.
13. Tanoli T., Yue P., Yablonskiy D., et al. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity. J Lipid Res 2004, 45:941-947.
14. Hooper A.J., Adams L.A., Burnett J.R. Genetic determinants of hepatic steatosis in man. J Lipid Res 2011, 52:593-617.
15. Romeo S., Kozlitina J., Xing C., et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008, 40:1461-1465.
16. Ludwig J., Viggiano T.R., McGill D.B., et al. Nonalcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980, 55:434-438.
17. Manolio T.A. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010, 363:166-176.
18. Sookoian S., Pirola C.J. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011, 53:1883-1894.
19. Speliotes E.K., Yerges-Armstrong L.M., Wu J., et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 2011, 7:e1001324.
20. Hernaez R., McLean J., Lazo M., et al. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the Third National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol 2013, 11:1183-1190.
21. Browning J.D. New imaging techniques for non-alcoholic steatohepatitis. Clin Liver Dis 2009, 13:607-619.
22. Palmer N.D., Musani S.K., Yerges-Armstrong L.M., et al. Characterization of European-ancestry NAFLD-associated variants in individuals of African and Hispanic descent. Hepatology 2013, April 8. Epub ahead of print.
23. Cohen J.C., Horton J.D., Hobbs H.H. Human fatty liver disease: old questions and new insights. Science 2011, 332:1519-1523.
24. He S., McPhaul C., Li J.Z., et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 2010, 285:6706-6715.
25. Chen W., Chang B., Li L., et al. Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease. Hepatology 2010, 16:16.
26. Chamoun Z., Vacca F., Parton R.G., et al. PNPLA3/adiponutrin functions in lipid droplet formation. Biol Cell 2013, 8:201200036.